Nicholas Eberstadt and Michael W. Hodin: America Needs to Rethink ‘Retirement’

Washington is abuzz over the politics of work. Will ObamaCare create jobs or destroy them? What would raising the minimum wage do to youth unemployment? And what to do about the long-term unemployed? Yet there is an odd political silence about a future vision for jobs and economic growth.

One vital question in particular goes largely unaddressed: How do we build an economic growth model for an aging society? As the over-60 population grows much faster than the younger working-age cohorts, while life expectancy increases, the 20th-century model of work and retirement becomes increasingly unsuitable for economic growth. The key will be finding new solutions to engage older Americans in the workforce.

With declining birthrates throughout much of the world, humanity is getting older. In Europe, the median age has climbed to 43 over the past 30 years, from 34, while in Japan-with the oldest population on the planet-the average age is 46, up from 39 in 1994. The American population is aging too (median age: just under 38), though more slowly thanks to immigration and a relatively high birthrate (almost two births per woman, in contrast to Japan’s 1.2-1.4). But this won’t last forever. The U.S. should adapt now or risk being less prosperous and competitive in the 21st century.

Research suggests that keeping older workers engaged in the economy will directly boost gross domestic product. In Japan, a 2005 study by the Nihon University Population Research Institute concluded that increasing the retirement age to 65 from 60 could raise per capita GDP 10% by 2025.

Calculations by the U.K.’s International Longevity Centre earlier this year suggest that increasing the total number of workers over 65 by just 2.6% a year could boost per capita output in 2037 by as much as 6%, cumulatively adding nearly £1.7 trillion to the U.K. economy-more than total British GDP today. Those estimates don’t take into account benefits from a longer work life to national wealth, budgets or public debt.

There is also mounting evidence that working later into life correlates with better individual health and satisfaction, and may contribute to them. Amid skyrocketing age-related health-care costs, this advantage can scarcely be overstated. Research by the Department of Work and Pensions in the U.K. found in 2006 that recipients of age-related entitlements “who move off benefits and re-enter work generally experience improvements in . . . mental and general health, and well-being.”

Thus at all levels of society-national, organizational and individual-there are advantages to redefining 20th-century retirement. The notion of establishing a fixed “retirement age,” with the state paying to support retirees, was introduced in Germany in 1889 by Chancellor Otto von Bismarck. The initial German retirement age was 70, later dropping to 65-but this was when life expectancy at birth was perhaps 40 years. Today, German life expectancy is over 80. Franklin Delano Roosevelt brought the same retirement age to the U.S. with Social Security in 1935, when U.S. life expectancy was 61, nearly two decades lower than today’s 79.

Yesterday’s way of thinking about aging must be replaced with something that makes sense for the 21st century. The U.S. can begin by pursuing three reforms.

First, we can change the culture by changing how we measure, and the measure of “unemployment” must better account for older adults. The Bureau of Labor Statistics should update its benchmarks for analyzing the job market. People in their 60s or 70s should be considered eligible for work-but the “unemployment rate” tells us only about conditions for those actively working or seeking work.

How about adding the “employment ratio”-the percentage of men and women 20 years of age and older holding jobs-to the key monthly labor-market indicators? Perhaps also the employment ratio for Americans over 55? That number would tell us that the “work rate” for older Americans has been rising for 20 years, a rare heartening fact about the U.S. workforce these days.

Second, we need policy changes, starting perhaps with a tax credit for firms that invest in training and education for older workers, encouraging what the Japanese are starting to call “silver entrepreneurs.” The Kauffman Foundation estimates that nearly half of all entrepreneurs in the U.S. are over 45. Since they are also among the most successful and productive, this is good policy as well as great business.

Another priority should be worker flexibility across the life-span: making pensions portable and creating incentives for education and training to provide continuing skill enhancement.

Third, corporations must change their approach to hiring, training and retaining talent to capture the abilities of older workers. Some organizations, such as the German car maker BMW, Home Instead Senior Care and the CVS drugstore chain, are already doing this, and it is proving to be good business.

Management of a BMW plant in Bavaria joined with older factory workers to identify how the site could be made “age friendly.” The small, cost-effective changes included softer floors, orthopedic footwear and adjustable workstations. Home Instead Senior Care’s older workers are better able to identify with and understand the needs of its clients. CVS is improving customer service by substantially increasing its over-50 workforce, having heard from customers that they appreciate the advice of older employees.

If human-resources executives took the lead, their influence would spread. Much of today’s “green” movement got its momentum when companies such as Johnson & Johnson, Whole Foods and General Electric got aboard, spreading the environmental message because it made good social and business sense. Though corporations would hire, train and rehire only a fraction of the older population, business leadership would influence society-wide perceptions.

The most common objection to encouraging older Americans to keep working is that they would “steal” the jobs of younger people and create a “gray ceiling.” This is mistaken. Similar arguments were once made about women entering the workforce, but it is now clear that their contributions have been a tremendous economic boon. According to the National Women’s Business Council, female-owned firms have an annual economic impact of $3 trillion and create or maintain more than 23 million jobs.

America’s aging population is a great untapped economic resource. The right policy reforms and business practices could leverage this resource to unleash another century of American economic growth. But first a profound transformation is needed in how we think about work, activity, aging and retirement.

Mr. Eberstadt is a resident scholar at the American Enterprise Institute. Mr. Hodin is executive director of the Global Coalition on Aging and a managing partner at the High Lantern Group.

Source: Wall Street Journal

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

Brazil Must Fight Antibiotic Resistance

The threat posed by antimicrobial resistance is urgent and spares no country - including Brazil. According to The Lancet, 63 deaths per 100,000 are associated with AMR in Brazil and Paraguay, a rate that exceeds the average for Latin America and the Caribbean. AMR-associated deaths in Brazil are second only to cardiovascular diseases and cancers.

We Missed 100 Million Adult Vaccines – Here’s How We Get Back on Track

Like other pandemics throughout human history, COVID-19 has caused profound changes that are still rippling through our societies, even as people are understandably eager to move on. In fact, these impacts are all the more dangerous when they are largely ignored or effectively invisible. The decline in adult vaccination may be one of the most significant, as a new report finds that ~100 million doses were missed in 2021 and 2022 alone – reversing global progress towards widespread adult immunisation as a new standard of care in a world of more old than young.

New Analysis Shows Lost Ground on Adult Immunisation During the Pandemic with 100 Million Doses Potentially Missed

New data shared today by GSK, in collaboration with the IQVIA Institute for Human Data Science and the Global Coalition on Aging (GCOA), estimate approximately 100 million fewer doses of some adult vaccines (excluding Covid-19 vaccines) were administered in 2021 and 2022 than anticipated, based on the global vaccination adoption trends observed from 2013 to 2020, compounding already low adoption rates pre-pandemic.

Going Beyond Applause: The Potential of Caregiving to Unlock Job Opportunities of the Future

Early in the COVID-19 pandemic, the role of caregivers – staff and family who provide care for older and dependent people to carry out activities such as eating or moving - catapulted to the front of our collective conscience. The daily applause for front-line care workers showed a high level of recognition for their incredible work and provided insight into how our health systems must change as our society ages. We need to continue to recognise caregivers as essential to our ageing society.

High-Level Forum on the Silver Economy 2023

Join us for the High-Level Forum on the Silver Economy 2023. Now in its fourth year, the Silver Economy Forum 2023, December 6 and 7, will explore aging at every stage of life, looking at the growing global Silver Economy through a multigenerational lens. Linking to the goals and aspirations of the UN Decade of Healthy Ageing, SEF 2023 will highlight key themes at the intersection of aging at every age, and the Silver Economy.

Global Coalition on Aging Workshop Calls on G7 Countries to Fund Pull Incentives to Spur Antibiotic Innovation

The Global Coalition on Aging, in partnership with JPMA, today announced the release of its workshop report on the AMR crisis facing G7 countries and the world, “The Value of Pull Incentives in Japan to Encourage Investment in Antibiotic Innovation to Solve the AMR Crisis.” If strong action is not taken to address AMR, we will lose the antibiotics we need to cure infections, which is likely to outpace cancer as a major cause of death, killing an estimated 10 million by 2050.